Guduchi ventures into USD 206 billion weight loss market with 'Obesidat'

Image
ANI New Delhi [India]
Last Updated : Nov 11 2016 | 6:22 PM IST

The Ayurvedism Guduchi has announced the nationwide release of the first scientifically proven research based Ayurvedic weight loss tablet Obesidat.

A revolutionary weight loss tablet, which works on correcting the cell to cell metabolism of individuals, will help users lose weight not by suppressing their appetite but by correcting their cell to cell metabolic system.

Guduchi has redefined today's weight loss market by introducing its innovative weight loss tablet that ensures that weight once lost will not be gained back.

Obesidat removes unwanted fat by correcting cell to cell metabolism of an individual, while most of the weight-loss products work by suppressing the appetite which is only a temporary solution.

As soon as Obesidat enters the blood vessels, it initiates cell to cell metabolism and helps in removing bad cholesterol from the blood vessels.

Obesidat prevents the formation of fatty liver by improving the function of the liver and by removing fat particles from the liver.

Obesidat removes plaque from the coronary arteries and is beneficial in heart ailments. It also dissolves plaque present in blood vessels in other parts of the body. Eg: Atherosclerosis of legs.

Obesidat enhances insulin release and absorption. This helps in maintaining sugar levels and body weight in diabetic patients.

Pricing and availability

Obesity is no more a rich man's disease keeping this in the mind Obesidat is priced economically where people can lose weight starting Rs 20/day using Obesidat.

Obesidat is available in all leading pharmacies in Bangalore and in chain pharmacies like Trust and Ayurcentral. While buyers from other parts of India and Internationals can place the order online on www.obesidat.com

Product development Method

Considering the socio-economical and health impacts of Obesity, Team Guduchi took pledge to control Obesity and thus formed a dedicated team of doctors in 2014 June to conduct a research on formulating a fool proof solution to combat obesity. Our team of doctors referred more than 18 ancient Ayurveda texts and created a unique formulation. This formulation and research was later approved by Department of AYUSH Karnataka. This formulation is further subjected to various critical tests like Acute Oral Toxicity Test and Anti Hyperlipidemia Test along with various quality tests in Ministry of Ayush Approved Research Laboratory.

After successful test results indicated that Obesidat is safe to consume and it does help in reducing the body weight by correcting the cell to cell metabolism, the formulation was later developed in the form of tablet in a GMP certified manufacturing facility.

All the scientific study reports along with the clinical study data are made available to public through the website www.obesidat.com for interested.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Nov 11 2016 | 6:22 PM IST

Next Story